![Pablo Cagnoni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pablo Cagnoni
President chez
INCYTE CORPORATION
Fortune : 23 M $ au 31/05/2026
Profil
Pablo J.
Cagnoni was the founder of Tizona Therapeutics, Inc., founded in 2015, where the titles held included President, Chief Executive Officer & Director from 2015 to 2018.
Current jobs include Director at Synthekine, Inc. since 2021; Director at Repertoire Immune Medicines, Inc.; Independent Director at Turmeric Acquisition Corp.; President, Head-Research & Development at Incyte Corp.
starting in 2026; Member-Governing Board at Biotechnology Innovation Organization; Member at Council on Foreign Relations, Inc.; and Trustee at Bay Area Discovery Museum.
Former jobs include Chief Executive Officer & Director at Laronde, Inc. from 2022 to 2023; Executive Chairman at Blade Therapeutics, Inc.; Chairman at Rubius Therapeutics, Inc. from 2022 to 2023; Director at Lycera Corp.; Managing Director at MPM BioImpact LLC from 2015 to 2016; Independent Non-Executive Director at CRISPR Therapeutics AG from 2016 to 2020; Director at Harpoon Therapeutics, Inc.; Director at Tango Therapeutics Sub, Inc.; Independent Director at Fusion Pharmaceuticals, Inc. from 2019 to 2024; Chief Medical Officer & Vice President at OSI Pharmaceuticals, Inc. from 2004 to 2007; President at Onyx Pharmaceuticals, Inc. from 2013 to 2015; Chief Medical Officer & Senior Vice President at Allos Therapeutics, Inc. from 2007 to 2009; Senior VP & Global Head-Clinical Development at Novartis AG from 2009 to 2013; Assistant Professor-Medicine at The University of Colorado; and Senior VP & Global Head-Clinical Development at Novartis Oncology, Inc. from 2009 to 2013.
Education includes a doctorate from the University of Buenos Aires School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INCYTE CORPORATION 0,12 % | 01/06/2026 | 240 848 ( 0,12 % ) | 23 M $ | 31/05/2026 |
Postes actifs de Pablo Cagnoni
| Sociétés | Poste | Début |
|---|---|---|
| TURMERIC ACQUISITION CORP. | Directeur/Membre du Conseil | - |
| INCYTE CORPORATION | President | 05/06/2023 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Synthekine, Inc.
 Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Directeur/Membre du Conseil | 04/02/2021 |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | - |
Bay Area Discovery Museum
 Bay Area Discovery Museum Other Consumer ServicesConsumer Services Operates as a preschool | Directeur/Membre du Conseil | - |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de Pablo Cagnoni
| Sociétés | Poste | Fin |
|---|---|---|
| FUSN PHAR | Directeur/Membre du Conseil | 04/06/2024 |
| RUBIUS THERAPEUTICS | Directeur Général | 15/11/2022 |
| ░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Pablo Cagnoni
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics | Health Technology |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Lycera Corp.
 Lycera Corp. Pharmaceuticals: MajorHealth Technology Develops novel oral medicines for treating autoimmune diseases and cancer | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Council on Foreign Relations, Inc.
Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Bay Area Discovery Museum
Bay Area Discovery Museum Other Consumer ServicesConsumer Services Operates as a preschool | Consumer Services |
University of Buenos Aires School of Medicine
 University of Buenos Aires School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Health Technology |
Synthekine, Inc.
Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
Turmeric Acquisition Corp.
 Turmeric Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Laronde Inc.
 Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Commercial Services |
